Franklin Resources Inc Viridian Therapeutics, Inc.\De Transaction History

Franklin Resources Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$9.55 - $19.0 $3.34 Million - $6.65 Million	-350,023 Reduced 58.33%	250,000 $2.89 Million
Q4 2021 Feb 11, 2022	BUY	$15.65 - $21.5 $359 - $494	23 Added 0.0%	600,023 $11.9 Million
Q3 2021 Nov 12, 2021	BUY	$10.69 - $18.2 $6.41 Million - $10.9 Million	600,000 New	600,000 $9.87 Million

179

76.8M

581K

439K

Ticker VRDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,888,900
Market Cap $839M
Description
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.